Patents by Inventor Veerle Bieghs

Veerle Bieghs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitis
    Patent number: 9393303
    Abstract: The invention is in the field of prevention and medical treatment of liver diseases, in particular non-alcoholic steatohepatitis (NASH). The invention provides means and methods for the treatment of hepatic inflammation, fibrosis and more in particular NASH. More in particular, the invention provides a composition capable of raising anti-oxLDL antibodies in vivo for use in the treatment of liver inflammation or fibrosis.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: July 19, 2016
    Assignees: Universiteit Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Ronit Sverdlov, Veerle Bieghs, Patrick Johannes Jacobus van Gorp
  • METHOD FOR TREATING LIVER INFLAMMATION, FIBROSIS AND NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20140044734
    Abstract: The invention is in the field of prevention and medical treatment of liver diseases, in particular non-alcoholic steatohepatitis (NASH). The invention provides means and methods for the treatment of hepatic inflammation, fibrosis and more in particular NASH. More in particular, the invention provides a composition capable of raising anti-oxLDL antibodies in vivo for use in the treatment of liver inflammation or fibrosis.
    Type: Application
    Filed: February 21, 2012
    Publication date: February 13, 2014
    Inventors: Ronit Sverdlov, Veerle Bieghs, Patrick Johannes Jacobus van Gorp
  • METHOD FOR TREATING FATTY LIVER DISEASES, IN PARTICULAR NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20130184246
    Abstract: The invention is in the field of medical treatments of liver disease, in particular, non-alcoholic fatty liver diseases, such as non-alcoholic steatohepatitis. The invention provides a composition comprising an effective amount of a compound capable of increasing the intracellular level of 27-hydroxycholesterol for the treatment of liver inflammation in fatty liver disease. It also provides a method of reducing liver inflammation in a patient with non-alcoholic fatty liver disease by administering an effective amount of 27-hydroxycholesterol.
    Type: Application
    Filed: July 30, 2011
    Publication date: July 18, 2013
    Inventors: Ronit Sverdlov, Veerle Bieghs, Patrick Johannes Jacobus Van Gorp